Darunavir



Darunavir (brand name Prezista, formerly known as TMC114) is a protease inhibitor medication used to treat HIV infection. Darunavir is an OARAC recommended treatment option for treatment-naïve and treatment-experienced adults and adolescents. It was approved by the Food and Drug Administration (FDA) on June 23, 2006.